Semaglutide and Tirzepatide, in addition to their use for type 2 diabetes management, have also demonstrated significant efficacy in promoting weight loss. There are notable differences between the two in their effects on weight reduction.
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that has been approved at a higher dose specifically for the treatment of obesity. It has shown remarkable weight loss results in clinical trials, with patients experiencing substantial reductions in body weight. Patients who coupled Semaglutide doses with better diets and exercise lost on average 15% of their initial weight.
On the other hand, tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist that has shown even more promising results in terms of weight loss. Clinical studies have reported greater reductions in body weight with Tirzepatide compared to Semaglutide. People taking Tirzepatide lost, on average, 22% of their starting weight
Unfortunately, we do not bill insurance for these drugs. We would be happy to provide you with a receipt so you can submit the charges to your insurance company if you like.
Semaglutide Weight Loss program – $274/month Tirzepatide Weight Loss Program – $349/month
All programs include the medication, the consultation, labs, supplies and shipping. There are absolutely NO additional costs or hidden fees.